3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Non-Muscle Invasive Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Neoplasms
3
Carcinoma, Transitional Cell
3
Urinary Bladder Neoplasms
2
Pancreatic Neoplasms
2
Lymphoma, B-Cell
2
Colorectal Neoplasms
2
Carcinoma
2
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Synovial
1
Platinum-resistant Ovarian Cancer
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Histologic Type
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Microsatellite Instability
1
Melanoma
1
Lung Neoplasms
1
Liposarcoma, Myxoid
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
Glioblastoma
1
Endometrial Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
pembrolizumab
25
Cisplatin
20
Carboplatin
14
Paclitaxel
11
Radiotherapy
9
Radiotherapy, Intensity-Modulated
8
Docetaxel
8
Cetuximab
8
Nivolumab
6
cemiplimab
5
Radiation
5
durvalumab
4
atezolizumab
3
Taxes
3
Surveys and Questionnaires
3
Fluorouracil
3
Drug Therapy
3
Cyclophosphamide
3
Blood Specimen Collection
3
toripalimab
2
olaparib
2
fludarabine
2
avelumab
2
alpha-2'-deoxythioguanosine
2
aldesleukin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
vistusertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
ALT-803
×
1 year
×
Clear all
No trials found.